hodgkin's lymphoma

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

Terminated
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 12, 2020

Hodgkin's Lymphoma Trial in United States (TGR-1202 + brentuximab vedotin)

Completed
  • Hodgkin's Lymphoma
  • TGR-1202 + brentuximab vedotin
  • Duarte, California
  • +3 more
Oct 1, 2019

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

Completed
  • Breast Cancer
  • +15 more
  • Encinitas, California
  • +23 more
Sep 20, 2018

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013